Podium Presentation Osteoarthritis

13.4.3 - Joint Space Width Criteria Can Reduce Knee OA Trial Heterogeneity: P2 Post-hoc Data From Wnt Pathway Inhibitor, SM04690 (ID 9669)

Presentation Number
13.4.3
Topic
Osteoarthritis
Lecture Time
13:39 - 13:48
Corresponding Author
  • J. Tambiah (San Diego, United States of America)
Authors
  • C. Lattermann (Lexington, United States of America)
  • J. Tambiah (San Diego, United States of America)
  • C. Swearingen
  • S. Kennedy (San Diego, United States of America)
  • A. Brett
  • M. Bowes
  • P. Conaghan
Disclosure
A.Brett, M.Bowes, iMorphics, Employee P.Conaghan, Flexion, AbbVie, Infirst, Medivir, EMDSerono, Novartis, ONO, Consultancy C.Lattermann, Samumed, Vericel, Cartiheal, Consultancy; ICRS, Board; AJSM, Cartilage, JKS, Ort J Sports Med, Reviewer S.Kennedy, C.Swearingen, J.Tambiah, Samumed, Employee